Integra End Period Cash Flow from 2010 to 2024

IART Stock  USD 21.80  0.09  0.41%   
Integra LifeSciences End Period Cash Flow yearly trend continues to be comparatively stable with very little volatility. End Period Cash Flow is likely to outpace its year average in 2024. From the period from 2010 to 2024, Integra LifeSciences End Period Cash Flow quarterly data regression had r-value of  0.78 and coefficient of variation of  79.52. View All Fundamentals
 
End Period Cash Flow  
First Reported
1995-12-31
Previous Quarter
215.2 M
Current Value
215.2 M
Quarterly Volatility
137.9 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Integra LifeSciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Integra LifeSciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 129.7 M, Interest Expense of 53.9 M or Total Revenue of 1.6 B, as well as many indicators such as Price To Sales Ratio of 4.18, Dividend Yield of 3.0E-4 or PTB Ratio of 3.52. Integra financial statements analysis is a perfect complement when working with Integra LifeSciences Valuation or Volatility modules.
  
Check out the analysis of Integra LifeSciences Correlation against competitors.

Latest Integra LifeSciences' End Period Cash Flow Growth Pattern

Below is the plot of the End Period Cash Flow of Integra LifeSciences Holdings over the last few years. It is Integra LifeSciences' End Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Integra LifeSciences' overall financial position and show how it may be relating to other accounts over time.
End Period Cash Flow10 Years Trend
Slightly volatile
   End Period Cash Flow   
       Timeline  

Integra End Period Cash Flow Regression Statistics

Arithmetic Mean204,274,940
Geometric Mean132,895,791
Coefficient Of Variation79.52
Mean Deviation131,403,253
Median138,838,000
Standard Deviation162,438,823
Sample Variance26386.4T
Range509.4M
R-Value0.78
Mean Square Error11009.4T
R-Squared0.61
Significance0.0006
Slope28,428,310
Total Sum of Squares369409.2T

Integra End Period Cash Flow History

2024290.2 M
2023276.4 M
2022456.7 M
2021513.4 M
2020470.2 M
2019198.9 M
2018138.8 M

About Integra LifeSciences Financial Statements

Integra LifeSciences shareholders use historical fundamental indicators, such as End Period Cash Flow, to determine how well the company is positioned to perform in the future. Although Integra LifeSciences investors may analyze each financial statement separately, they are all interrelated. The changes in Integra LifeSciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Integra LifeSciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
End Period Cash Flow276.4 M290.2 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Integra Stock Analysis

When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.